| Ariad's New Deal With Merck Refills Its Coffers The Burrill Report submits: By Michael FitzhughMerck (MRK) will pay Ariad Pharmaceuticals (ARIA) about $69 million plus milestones for exclusive rights to the Cambridge, Massachusetts-based company’s late-stage soft tissue cancer drug ridaforolimus, replenishing Ariad's waning cash reserves as it revs up a new trial on its next experimental drug, AP24534, a therapy for chronic myeloid leukemia and other cancers.Complete Story » seekingalpha.com |
NeoGenomics Provides Early Look at Second Quarter Results (PR Newswire) NeoGenomics, Inc. announced today that it expects to report second quarter revenue of approximately $8.5 million and a net loss of approximately – per share.  Revenues and test volumes increased by approximately 14% and 28%, respectively, compared to last year's second quarter.  These comparisons are impacted by the previously disclosed internalization of certain bladder cancer FISH testing by the Company's largest customer beginning in June 2009.  Excluding this one account, revenues and test volumes grew by approximately 23% and 39%, respectively, versus last year.  Revenue growth in the second quarter was also adversely impacted by further declines in average unit pricing, expanded efforts by large insurance companies to reduce testing and payments to "out-of-network" laboratories, and the overall challenging economy and its corresponding impact on sales force productivity. us.rd.yahoo.com |
NeoGenomics Reports Second Quarter 2010 Results (PR Newswire) NeoGenomics, Inc. , a leading provider of cancer-focused genetic testing services today reported its results for the second quarter 2010. us.rd.yahoo.com |
Nanoneedles Deliver Drugs China's Suzhou Natong Bionanotechnology hopes its drug-delivery device could help eliminate the danger to doctors and nurses of accidental sticking and allow greater product lifetime for pharmaceutical companies. online.wsj.com |
Council Sets Abortion Fight The City Council plans to unveil legislation Tuesday that would establish strict disclosure requirements for crisis-pregnancy centers, some of which, abortion-rights advocates charge, deceive women. online.wsj.com |